MSP Recovery to be Downgraded to OTC Expert Market Due to Non-Compliance
MSPR sits 81% above its 52-week low of $0.011.
Summary
MSP Recovery, Inc. will be downgraded to the OTC Expert Market on July 17, 2026, due to its failure to file required financial reports, severely restricting stock trading and liquidity.
Key Events · Corporate Governance and Compliance · MSPR
-
OTC Expert Market Downgrade
The company's Class A common stock and publicly traded warrants will move from the OTC Pink Limited Information market tier to the OTC Expert Market on or around July 17, 2026.
-
Failure to File Reports
The downgrade is a direct result of the company's non-compliance with SEC reporting obligations, specifically the failure to file its 2025 Annual Report on Form 10-K and Q1 2026 Quarterly Report on Form 10-Q.
-
Restricted Trading
The Expert Market is limited to unsolicited quotes from broker-dealers for certain retail and institutional investors, significantly reducing liquidity and public access to the stock.
-
No Expected Compliance
MSP Recovery does not expect to file the delayed reports by the July 17, 2026, deadline, confirming the impending downgrade.
Analysis · MSPR · Technology
MSP Recovery, Inc. faces a critical downgrade to the OTC Expert Market effective July 17, 2026. This move is a direct consequence of the company's failure to file its 2025 Annual Report on Form 10-K and Q1 2026 Quarterly Report on Form 10-Q. Trading on the Expert Market is severely restricted, allowing only unsolicited quotes from sophisticated investors, which will significantly reduce liquidity and investor access. The company explicitly stated it does not expect to regain compliance by the deadline, confirming the downgrade will proceed. This follows a pattern of severe liquidity issues and previous downgrades, further isolating the company from public markets.
At the time of this filing, MSPR was trading at $0.02 on OTC in the Technology sector, with a market capitalization of approximately $283.6K. The 52-week trading range was $0.01 to $59.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.